Novo Nordisk Raises Guidance as Wegovy Pill Rollout Continues
The Danish drugmaker cited an improved outlook for its obesity and diabetes drugs, particularly outside the U.S. The body is truncated before the revised guidance details.
Story updates
07:35:42 AM UTC
SquawkNews
NOVO NORDISK SHARES SEEN UP 3-4% AFTER Q3 BEAT, GUIDANCE UPGRADE - TRADERS
By Dominic ChoppingNovo Nordisk raised its guidance for the year after noting an improved outlook for its key obesity and diabetes drugs, particularly in markets outside of the U.S., as it continues the rollout of its new weight-loss pill.The Danish drugmaker said Wednesday that it expects adjusted…